Hypersensitivity, Delayed
"Hypersensitivity, Delayed" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
| Descriptor ID |
D006968
|
| MeSH Number(s) |
C20.543.418
|
| Concept/Terms |
Hypersensitivity, Delayed- Hypersensitivity, Delayed
- Hypersensitivity, Type IV
- Hypersensitivities, Type IV
- Type IV Hypersensitivities
- Delayed Hypersensitivity
- Delayed Hypersensitivities
- Hypersensitivities, Delayed
- Type IV Hypersensitivity
- Hypersensitivity, Tuberculin-Type
- Hypersensitivities, Tuberculin-Type
- Hypersensitivity, Tuberculin Type
- Tuberculin-Type Hypersensitivities
- Tuberculin-Type Hypersensitivity
- Tuberculin Type Hypersensitivity
|
Below are MeSH descriptors whose meaning is more general than "Hypersensitivity, Delayed".
Below are MeSH descriptors whose meaning is more specific than "Hypersensitivity, Delayed".
This graph shows the total number of publications written about "Hypersensitivity, Delayed" by people in this website by year, and whether "Hypersensitivity, Delayed" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypersensitivity, Delayed" by people in Profiles.
-
Transition from metal-DTH resistance to susceptibility is facilitated by NLRP3 inflammasome signaling induced Th17 reactivity: Implications for orthopedic implants. PLoS One. 2019; 14(1):e0210336.
-
Metal sensitivities among TJA patients with post-operative pain: indications for multi-metal LTT testing. J Long Term Eff Med Implants. 2014; 24(1):37-44.
-
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.
-
Metal-on-metal bearing surfaces. J Am Acad Orthop Surg. 2009 Feb; 17(2):69-76.
-
Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2004 Apr 01; 35(4):383-92.
-
Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen. J Infect Dis. 2003 Nov 15; 188(10):1444-54.
-
Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001 Jan 01; 19(1):145-56.
-
A triple assay technique for the evaluation of metal-induced, delayed-type hypersensitivity responses in patients with or receiving total joint arthroplasty. J Biomed Mater Res. 2000 Sep; 53(5):480-9.
-
Hypersensitivity to metallic biomaterials: a review of leukocyte migration inhibition assays. Biomaterials. 2000 Jul; 21(13):1301-14.
-
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group. AIDS. 2000 Jan 07; 14(1):11-21.